Similarity | Rank | |
---|---|---|
randomised | 0.945 | 46929 |
double-blind | 0.919 | 34234 |
placebo-controlled | 0.906 | 42426 |
multicenter | 0.903 | 69465 |
open-label | 0.898 | 89583 |
Randomized | 0.887 | 93743 |
RCTs | 0.852 | 82390 |
meta-analysis | 0.843 | 39189 |
case-control | 0.842 | 83586 |
randomization | 0.799 | 71762 |
population-based | 0.795 | 69592 |
placebo | 0.792 | 12334 |
monotherapy | 0.767 | 66795 |
high-dose | 0.765 | 58378 |
prospectively | 0.752 | 71458 |
low-dose | 0.751 | 57276 |
well-controlled | 0.748 | 96583 |
bevacizumab | 0.742 | 94024 |
clinical | 0.741 | 2463 |
METHODS | 0.733 | 45074 |
epidemiologic | 0.731 | 72423 |
investigational | 0.724 | 62099 |
pharmacokinetic | 0.717 | 73658 |
once-daily | 0.716 | 95649 |
dose-response | 0.713 | 97933 |